COMPANY

Quiver Bioscience Inc.

HQ: Cambridge, MA source · quiverbioscience.com ↗ · New England

Keywords: From press sources:RNA therapeutics machine learning chronic pain

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

19NIH grants

NIH awards 19

Annual award amounts. Total $16.2M.

May 5, 2026 NIH award 5R44NS141534-02 FY2026: $886,042 awarded for that fiscal year; activity R44 (SBIR); PI SIMAO, FABRICIO; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Safe-OPTION: Optical Physiology To Interr source ↗
Apr 28, 2026 NIH award 1UG3NS146009-01 FY2026: $1,993,248 awarded for that fiscal year; activity UG3 (OTHER_NIH); PI ZHANG, HONGKANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Development of Nav channel targeti source ↗
Jun 10, 2025 NIH award 3R44NS125689-07S1 FY2025: $51,450 awarded for that fiscal year; activity R44 (SBIR); PI LU, YANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Ultra-High-Throughput Plate Reader for Drug Dis source ↗
May 20, 2025 NIH award 1R44NS141534-01 FY2025: $862,420 awarded for that fiscal year; activity R44 (SBIR); PI SIMAO, FABRICIO; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Safe-OPTION: Optical Physiology To Interr source ↗
Aug 13, 2024 NIH award 5R44NS125689-07 FY2024: $251,085 awarded for that fiscal year; activity R44 (SBIR); PI LU, YANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Ultra-High-Throughput Plate Reader for Drug Disc source ↗
Aug 1, 2024 NIH award 5R44MH135521-02 FY2024: $1,278,054 awarded for that fiscal year; activity R44 (SBIR); PI WILLIAMS, LUIS ALBERTO; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. BRITE-Eye: An integrated discove source ↗
Jul 29, 2024 NIH award 5R44MH122052-05 FY2024: $378,127 awarded for that fiscal year; activity R44 (SBIR); PI HARWOOD, BENJAMIN NATHANIEL; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Functional drug fingerprintin source ↗
Sep 19, 2023 NIH award 1R44MH135521-01 FY2023: $1,721,943 awarded for that fiscal year; activity R44 (SBIR); PI WILLIAMS, LUIS ALBERTO; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. BRITE-Eye: An integrated discove source ↗
Sep 15, 2023 NIH award 5R44NS125689-06 FY2023: $961,962 awarded for that fiscal year; activity R44 (SBIR); PI LU, YANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Ultra-High-Throughput Plate Reader for Drug Disc source ↗
Sep 8, 2023 NIH award 6R44NS125689-05 FY2022: $1,228,439 awarded for that fiscal year; activity R44 (SBIR); PI LU, YANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Ultra-high-throughput plate reader for drug di source ↗
Jul 27, 2023 NIH award 6R44MH121169-03 FY2023: $635,498 awarded for that fiscal year; activity R44 (SBIR); PI RYAN, STEVEN JOHN; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. A phenotypic screen for compounds that source ↗
Jul 1, 2023 NIH award 6R44MH122052-04 FY2023: $793,383 awarded for that fiscal year; activity R44 (SBIR); PI HARWOOD, BENJAMIN NATHANIEL; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Functional drug fingerprintin source ↗
Jul 29, 2022 NIH award 4R44MH121169-02 FY2022: $995,203 awarded for that fiscal year; activity R44 (SBIR); PI RYAN, STEVEN JOHN; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. A phenotypic screen for compounds that source ↗
May 26, 2022 NIH award 5R44CA247110-03 FY2022: $995,305 awarded for that fiscal year; activity R44 (SBIR); PI ZHANG, HONGKANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Development of anti-sense oligonucleotide source ↗
Sep 6, 2021 NIH award 5R44AR074820-03 FY2021: $696,518 awarded for that fiscal year; activity R44 (SBIR); PI ZHANG, HONGKANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. A phenotypic screen for osteoarthritic pa source ↗
May 25, 2021 NIH award 4R44CA247110-02 FY2021: $1,000,001 awarded for that fiscal year; activity R44 (SBIR); PI ZHANG, HONGKANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Development of anti-sense oligonucleoti source ↗
Sep 7, 2020 NIH award 1R44CA247110-01A1 FY2020: $300,728 awarded for that fiscal year; activity R44 (SBIR); PI ZHANG, HONGKANG; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. Development of anti-sense oligonucleoti source ↗
Aug 24, 2020 NIH award 4R44AR074820-02 FY2020: $892,810 awarded for that fiscal year; activity R44 (SBIR); PI LIU, PIN; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. A phenotypic screen for osteoarthritic pain ther source ↗
Sep 20, 2019 NIH award 1R44AR074820-01A1 FY2019: $230,695 awarded for that fiscal year; activity R44 (SBIR); PI LIU, PIN; recipient as written: QUIVER BIOSCIENCE INC., CAMBRIDGE, MA. A phenotypic screen for osteoarthritic pain th source ↗

Funding and NIH signals

NIH award NIH awarded $886K (SBIR Phase II 5R44NS141534-02, continuation, notice May 5, 2026); 2 NIH awards totaling $2.88M in the last 12 months. NIH RePORTER 5R44NS141534-02 (May 5, 2026)
Evidence (2 events)
- May 5, 2026 · NIH RePORTER 5R44NS141534-02
  Organization: QUIVER BIOSCIENCE INC.; City/State: CAMBRIDGE, MA; Project number: 5R44NS141534-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-05; FY total cost (award amount): 886042; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Safe-OPTION: Optical Physiology To Interrogate Oligonucleotide Neurotoxicity; Organization type: Domestic For-Profits
- Apr 28, 2026 · NIH RePORTER 1UG3NS146009-01
  Organization: QUIVER BIOSCIENCE INC.; City/State: CAMBRIDGE, MA; Project number: 1UG3NS146009-01; Activity code: UG3; Fiscal year: 2026; Award notice date: 2026-04-28; FY total cost (award amount): 1993248; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Development of Nav channel targeting antisense oligonucleotides as chronic pain therapeutics using an integrated platform based on machine learning and optical electrophysiology; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals